Table 1 Patient demographics
n (%) | |
|---|---|
All patients | 241 (100) |
Age (y) | |
Median | 65 |
Range | 46–79 |
T classification at diagnosis | |
T1 | 148 (61.4) |
T2a | 75 (31.1) |
T2b | 9 (3.7) |
T2c-3 | 9 (3.7) |
Gleason score at diagnosis | |
≤ 6 | 208 (86.3) |
7 | 26 (10.8) |
≥ 8 | 2 (0.8) |
NA | 5 (2.1) |
PSA at diagnosis (ng/ml) | |
PSA ≤ 10 | 165 (68.5) |
PSA 10.1–19.9 | 71 (29.5) |
PSA ≥ 20 | 5 (2.1) |
D’Amico risk group | |
Low | 142 (58.9) |
Intermediate | 85 (35.3) |
High | 14 (5.8) |
Short term ADT | |
No | 188 (78.0) |
Yes | 53 (22.0) |